Grifols

Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide. 

Over the years we have established successful relationships with customers in global markets, including North America, Canada, Australia, and Europe in the following areas:

• Generic drug development and manufacturing

Grifols Partnership has two FDA and GMP approved manufacturing facilities in Spain for intravenous solutions that have parametric release certification.

We specialize in small molecule intravenous solutions and offer high quality pharmaceutical development and product manufacturing. Our portfolio also includes products which require careful design and assembly including medical devices and bags for blood storage and collection.

• Flexible Containers (PP bags, 50 to 1000 mL)


Address: Av. de la Generalitat, 152-158, 08174 Sant Cugat del Vallès, Barcelona, Spain
Tel. +34935712199
Fax: +34935710474


Articles

Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide.

Grifols International, S.A.

	Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide.

	Over the years we have established successful relationships with customers in global markets, including North America, Canada, Australia and Europe in the following areas:

	   •    Human & Veterinary fields
	   •    New product development
	   •    Validation batches
	   •    Generic drug development and manufacturing

	Grifols Partnership has two FDA and GMP approved manufacturing facilities in Spain for intravenous solutions that have parametric release certification.

	We specialize in small molecule intravenous solutions and offer high quality pharmaceutical development and product manufacturing. Our portfolio also includes products which require careful design and assembly including medical devices and bags for blood storage and collection.

	   •    Drug Product Development
	   •    Small Molecule Drug Products
	   •    Terminal Sterilization
	   •    Light and O2 sensitive products
	   •    Emulsion Technology
	   •    Vials (5 to 50 mL)
	   •    Diluents
	   •    Glass Bottles (50 to 500 mL)
	   •    Flexible Containers (PP bags, 50 to 1000 mL)
	   •    FFS technology for PP bags
	   •    Regulatory Approvals

	Company name: Grifols International S.A
	Website: 


	Stand/Booth number: Hall 12.1, Booth 121C70

Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with over 75 years’ experience in producing intravenous solutions for the pharmaceutical industry worldwide.

Grifols International S.A

	Address: Av. de la Generalitat, 152-158, 08174 Sant Cugat del Vallès, Barcelona, Spain

	Grifols is one of the world’s leading pharmaceutical companies with 30 subsidiaries, and operations in more than 100 countries. Grifols Partnership is a CDMO for parenteral solutions and lipid emulsions with over 75 years’ experience in producing intravenous solutions for the pharmaceutical industry worldwide. A solid commitment to quality makes Grifols Partnership a reliable and efficient strategic partner for your contract manufacturing needs.

	Our high level of specialization allows us to offer pharmaceutical development and manufacturing for products that require advanced technology and complex production processes.
	Grifols Partnership has two FDA and GMP approved manufacturing facilities in Spain for intravenous solutions that have parametric release certification.

	Grifols Partnership works together with the customer from the early stages of development to commercial manufacturing industrial batches.

	   •    Pre-formulation and development
	   •    Scale-up and technology transfer of methods
	   •    Validation batches
	   •    Process scale-up and pilot production including 10/300L reactors
	   •    ICH stability studies
	   •    Analytical development and validation
	   •    Clinical batches
	   •    Dossier support documentation
	   •    Commercial manufacturing of industrial batches
	   •    Labelling and packaging


	   •    Aqueous (LVP & SVP)
	   •    Diluents for reconstitution
	   •    Emulsion technology
	   •    Form Fill Seal (FFS) technology for PP bags
	   •    Manufacture and filling of oxygen and light sensitive products
	   •    Terminal sterilization
	   •    Serialization


	   •    Vials: 5ml to 50ml, glass
	   •    Glass Bottles: 50ml to 500ml
	   •    Flexible Polypropylene IV Bags: 50ml to 3000ml

	   •    Pre-formulation and development
	   •   Scale-up and technology transfer of methods
	   •   Validation batches
	   •   Process scale-up and pilot production including 10/300L reactors
	   •   ICH stability studies
	   •   Analytical development and validation
	   •   Clinical batches
	   •   Dossier support documentation
	   •   Commercial manufacturing of industrial batches
	   •   Labelling and packaging


	   •    Aqueous (LVP & SVP)
	   •   Diluents for reconstitution
	   •   Emulsion technology
	   •   Form Fill Seal (FFS) technology for PP bags
	   •   Manufacture and filling of oxygen and light sensitive products
	   •   Terminal sterilization


	   •   Vials: 5ml to 50ml, glass
	   •   Glass Bottles: 50ml to 500ml
	   •   Flexible Polypropylene IV Bags: 50ml to 3000ml